Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Nabriva Therapeutics AG (NBRVF)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
0.0001 0.0000    0.00%
17/04 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.0000 / 0.0000
  • Day's Range: 0.0001 - 0.0010
Nabriva Therapeutics 0.0001 0.0000 0.00%

Nabriva Therapeutics AG Company Profile

 
Get an in-depth profile of Nabriva Therapeutics AG, including a general overview of the company's business and key management, as well as employee data and location and contact information.
IndustryBiotechnology & Medical Research
SectorHealthcare
Employees

39

Equity Type

ADR

Nabriva Therapeutics plc, a biopharmaceutical company, engages in the development and commercialization of novel anti-infective agents to treat serious infections. The company’s product includes SIVEXTRO, an oxazolidinone-class antibacterial for the treatment of acute bacterial skin and skin structure infection (ABSSSI); and XENLETA, a semi-synthetic pleuromutilin antibiotic for oral and IV administration. It also develops XENLETA that is in Phase I clinical trial for the treatment of pediatric infections, as well as sexually transmitted infections, cystic fibrosis, ABSSSI, ventilator-associated bacterial pneumonia, complicated intra-abdominal infections, hospital-acquired bacterial pneumonia, acute bacterial skin and skin structure infections, osteomyelitis, and prosthetic joint infections. In addition, the company develops CONTEPO, an epoxide antibiotic for use in treating complicated urinary tract infections, as well as is in Phase I clinical trial for peri-operative prophylaxis. The company was formerly known as Nabriva Therapeutics Forschungs GmbH and changed its name to Nabriva Therapeutics plc in 2007. Nabriva Therapeutics plc was incorporated in 2005 and is headquartered in Dublin, Ireland.

Contact Information

Address Alexandra House Office 225/227
The Sweepstakes Dublin, 4
Ireland
Phone 353 1 649 2000
Fax -

Top Executives

Name Age Since Title
Stephen W. Webster 62 2017 Independent Director
Colin Broom 67 2014 Director
Charles A. Rowland 65 2017 Independent Director
Mark H. N. Corrigan 65 2021 Independent Director
Steven P. Gelone 55 2014 Director
Daniel D. Burgess 61 2016 Independent Chairman of the Board
Lisa Dalton 49 2021 Independent Director
Theodore R. Schroeder 69 2018 Director
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

NBRVF Comments

Write your thoughts about Nabriva Therapeutics AG
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Casper Lind
Casper Lind Nov 04, 2023 3:31AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
does anybody know what is going on with this shock?
Casper Lind
Casper Lind Jan 06, 2023 11:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
unbelievable
Constantino Garcia Casado
Constantino Garcia Casado Aug 29, 2022 9:56AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Sin centurion no sube, no arranca
Carlos Martínez
Carlos Martínez Aug 05, 2022 7:01AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Terrible inversión
Francisco Tavares
Francisco Tavares Nov 22, 2021 12:59PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happened today?
Casper Lind
Casper Lind Nov 11, 2021 4:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
what happened yesterday. Why this sudden dropped? Does someone know?
גרגורי ליובוצקי
גרגורי ליובוצקי Nov 11, 2021 4:20AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Before 🚀
Nadezhda Krukovskaya
Nadezhda Krukovskaya Nov 04, 2021 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
47$ after earning
Alexander Cappellua
Alexander Cappellua Nov 04, 2021 3:29PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
criptomonedas ripple cardano
criptomonedas ripple cardano Sep 08, 2021 7:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
nabrivia 5 $
גרגורי ליובוצקי
גרגורי ליובוצקי Sep 08, 2021 7:46AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Today
WTI Trader
WTI Trader Aug 05, 2021 7:38PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Up 14%
Eduard Garriga
Eduard Garriga Aug 05, 2021 8:40AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Resultados a cierre de hoy
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email